SB
ASMB icon

Samsara BioCapital’s Assembly Biosciences ASMB Stock Holding History

Samsara BioCapital’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-2,478
Closed -$694K – 38
2020
Q2 		$694K Buy
+2,478
New +$578K 0.22% 29

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Samsara BioCapital's ASMB Position: Q3 2020 in Review

Samsara BioCapital sold out of Assembly Biosciences (ASMB) in Q3 2020, closing a stake of 2,478 shares — an estimated $694K sold.

Samsara BioCapital first reported a position in ASMB in Q2 2020 and held it in 1 quarter. The position peaked at $694K in Q2 2020. 118 funds tracked by Wall St. Rank hold ASMB as of Q3 2020.

  • Samsara BioCapital reported no remaining Assembly Biosciences position as of Q3 2020 after selling out during the quarter.
  • Samsara BioCapital sold 2,478 Assembly Biosciences shares in Q3 2020, an estimated $694K.
  • Samsara BioCapital first reported a position in Assembly Biosciences in Q2 2020 and held it in 1 quarter.
  • Samsara BioCapital's Assembly Biosciences position peaked at $694K in Q2 2020.
  • 118 funds tracked by Wall St. Rank held Assembly Biosciences as of Q3 2020.

Based on Samsara BioCapital's 13F filing for Q3 2020, filed 16 Nov 2020.